Product record

Sitagliptin Metformin +: batches declared Not of Standard Quality

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts, Jan 2019, Jul 2026

2 batches of products named "Sitagliptin Metformin +" (as printed by the testing lab) failed a CDSCO or state drug-testing laboratory test between May 2025 and June 2025. This is a record of specific batches, it does not mean the molecule or every brand is unsafe.

Records by type

2 records linked to Sitagliptin Metformin + in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, May 2025 to Jun 2025

View original document

Scope. A failed batch is not a verdict on every pack of this product. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches
2
Manufacturers
Assay
Most common reason
Jun 2025
Latest alert

Flagged batches

Batch Manufacturer Reason declared NSQ Tested by Alert
T-2672Mfg 2024-09 · Exp 2026-08 Jackson Laboratories Pvt.Ltd 22-24Punjab Assay of SitagliptinAssay CDL KolkataCDSCO lab Jun 2025
T-2916Mfg 2024-09 · Exp 2026-08 Jackson Laboratories Pvt. LtdPunjab Assay of SitagliptinAssay CDL, KolkataCDSCO lab May 2025

How to use this. Match the batch number on your strip or bottle against the list. If your batch is listed, return it to the pharmacy and ask for a replacement; if not, the product is not on any alert as of July 2026. Check any batch number.